EMJ Dermatology 5.1 2017

The European Medical Journal is a specialist publisher who combines leading editorials from key opinion leaders with a concise news coverage from the leading congresses within the industry, delivering world-class insights to the key developments and advancements within both clinical and pharmaceutical areas.

We are committed to advancing learning, knowledge, and research worldwide. We aim to publish quality, peer reviewed, and fully indexed Journals. Our unrivalled collaborations with eminent, independent industry bodies create a dynamic tool which assists physicians, clinicians, and leading industry professionals to continuously develop their effectiveness and productivity.

Aims and Scope

  • The European Medical Journal (EMJ) is an online only, peer reviewed, open access general journal, targeted towards readers in the medical sciences. We aim to make all our articles accessible to readers from any medical discipline
  • EMJ allows healthcare professionals to stay abreast of key advances and opinions across Europe
  • EMJ aims to support healthcare professionals in continuously developing their knowledge, effectiveness, and productivity. The editorial policy is designed to encourage discussion among this peer group
  • EMJ is published quarterly and comprises of review articles, case reports, practice guides, theoretical discussions, and original research
  •  EMJ also publishes 16 therapeutic area journals, which provide concise coverage of salient developments at the leading European congresses. These are published annually, approximately 6 weeks after the relevant congress. Further details can be found on our website: www.emjreviews.com

 

Editorial Expertise

EMJ is supported by various levels of expertise:

  • Guidance from an Editorial Board consisting of leading authorities from a wide variety of disciplines
  • Invited contributors are recognised authorities from their respective fields
  • Peer review, which is conducted by EMJ’s Peer Review Panel as well as other experts appointed due to their knowledge of a specific topic
  • An experienced team of editors and technical editors

 

Peer Review

  • On submission, all articles are assessed by the editorial team to determine their suitability for the journal and appropriateness for peer review
  • Editorial staff, following consultation with either a member of the Editorial Board or the author(s) if necessary, identify three appropriate reviewers, who are selected based on their specialist knowledge in the relevant area
  • All peer review is double blind
  • Following review, papers are either accepted without modification, returned to the author(s) to incorporate required changes, or rejected
  • Editorial staff have final discretion over any proposed amendments

 

Submissions​

  • Contributors are identified and invited by editorial staff with guidance from the Editorial Board
  • Following acceptance of an invitation, the author(s) and editorial staff formalise the working title and scope of the article
  • Editorial staff will provide instructions to authors, or submission details can be found through our website: www.emjreviews.com
  • Editorial staff are always keen to hear from healthcare professionals wishing to discuss potential submissions

 

Reprints

  • All articles included in EMJ are available as reprints (minimum order 1,000). Please contact contact@emjreviews.com if you would like to order reprints

 

Distribution and Readership​

  • EMJ is distributed through controlled circulation to healthcare professionals in the relevant fields across Europe

 

Indexing and Availability​

  • EMJ is indexed on DOAJ, the Royal Society of Medicine, and Google Scholar; selected articles are indexed in PubMed Central
  • EMJ is available through the websites of our leading partners and collaborating societies
  • EMJ journals are all available via our website: emjreviews.com

Comments are closed.